Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

NCT07234903 is registered in ClinicalTrials.gov with Ecole Polytechnique Fédérale de Lausanne as lead sponsor.

NCT NCT07234903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07234903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
Lead sponsor
Ecole Polytechnique Fédérale de Lausanne
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2026
Completion date
April 30, 2032
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spinal cord injury, sci, sci - spinal cord injury, spinal cord injury, spinal cord injury (sci), subacute spinal cord injury